The biopharmaceutical industry demands exacting standards in quality assurance and quality control (QA/QC). Precision and consistency in laboratory operations are critical as companies navigate complex regulatory environments. A Laboratory Information Management System (LIMS) tailored for biopharmaceutical QA/QC significantly enhances operational efficiency, ensures regulatory compliance, and improves data integrity. 

LIMS supports biopharmaceutical labs by automating workflows, enhancing data accuracy, and enabling real-time decision-making.  

View original content: https://www.prnewswire.com/news-releases/labware-continues-to-provide-leadership-through-strategic-partnerships-and-innovation-in-irelands-biopharma-sector-302163156.html

WILMINGTON, Del., June 4, 2024 /PRNewswire/ -- LabWare, a global leader in Laboratory Information Management Systems (LIMS) within the Pharma and BioPharma industry, last month played a key role in spearheading and guiding an exploratory delegation led by the Governor of Delaware to investigate and exchange opportunities within Ireland's BioPharma sector. This visit focused on Ireland's success in biopharmaceutical manufacturing, fostering collaborations, exploring innovation, and leveraging valuable insights from LabWare. Other participants included the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) and the University of Delaware. 

Patrick Callahan, LabWare's Director of Analytics and Tom Brohan, LabWare's Ireland Service Delivery Manager, the sole industry participants, engaged with esteemed organizations, including Ireland's National Institute for Bioprocessing Research and Training (NiBRT,  the University of Limerick, Trinity College, regional economic development entities like IDA Ireland and The Science Foundation Ireland Research Centre for Pharmaceuticals (SSPC) and several of LabWare's BioPharma clients including Astra Zeneca. 

During the delegation visit, key observations were made: 

• Advancements in Ireland's Biopharmaceutical Manufacturing: Substantial investments in workforce development, government incentives, and robust collaboration between government, industry, and academia have all contributed to their progress.
• Growth in BioPharma Manufacturing and Research and Development: Ireland's trajectory in Manufacturing and R&D, backed by venture capital and state-of-the-art facilities, presents significant opportunities.
• Technology Companies' Interest: Major tech players like Amazon, Microsoft, and Google are intensifying their focus on Ireland's BioPharma sector, indicating a conducive environment for innovation.
• Commitment to Science Education: Ireland's early investment in science education nurtures a skilled workforce and fosters collaborative research initiatives.

Patrick Callahan, representing LabWare, remarked, "Our engagement and leadership with Ireland's BioPharma sector has been key to our growth in the BioPharma industry. The commitment to innovation and collaboration we have witnessed aligns perfectly with LabWare's ethos of driving technological advancements in the biopharmaceutical industry and our investment in scientific education." 

LabWare identified numerous collaboration and expansion opportunities during the visit, reinforcing its commitment to advancing technology integration and strategic partnerships within the global biopharmaceutical landscape. 

This experience underscores LabWare's dedication to innovation and collaboration in driving the biopharmaceutical industry forward.  

"As an Ireland native and long-term employee of LabWare, I am proud to see the significance of software advancements in the Biopharmaceutical space and showcase what has transpired in our country.  We look at this as illuminating the path for future innovations in the U.S." says Tom Brohan, LabWare's Ireland representative.  

The Role of Quality Control in Biopharma Lab Operations

Quality control (QC) serves as the vital heartbeat within the dynamic realm of biopharmaceutical laboratories. Beyond ensuring adherence to rigorous regulatory standards, QC emerges as a central player in continually enhancing laboratory operations and the meticulous collection of essential data. This pivotal role involves maintaining compliance and contributing significantly to the overall efficiency, reliability, and quality of processes within biopharma lab operations. By upholding rigorous quality standards, QC becomes a cornerstone for fostering excellence, reliability, and precision in pursuing innovative solutions and developing safe and effective biological medicines.

Lüneburg, DE / Delaware, US

LabWare® has achieved the “Ready” level required to join Körber's Ecosystem of partner companies.

With that, the two companies are taking the seamless integration capabilities between LabWare’s LIMS (Laboratory Information Management System) and Körber’s PAS-X MES (Manufacturing Execution System) to a new level of cooperation.

Körber's collaboration with LabWare marks the next milestone following the launch of Körber's "PAS-X LIMS Integration" program, a new element within the Körber Ecosystem. This program offers customers improved convenience in identifying LIMS suppliers compatible with PAS-X MES. It demonstrates to customers that Körber and its partners can significantly reduce the effort and risk involved in integrating LIMS with Körber's world-leading Manufacturing Execution System PAS-X MES by using a standardized interface. 

LabWare, a trusted partner to most of the top 25 global pharmaceutical companies and a worldwide leader in laboratory informatics, brings profound expertise and operational excellence to this relationship. “Our LIMS is used at more than 29,000 laboratories with more than 150,000 daily users and a billion samples tested a year,” says Mark Gonzalez, Technical Director at LabWare. As a certified partner, LabWare demonstrates seamless integration capabilities with PAS-X MES. “The successful collaboration between LabWare and Körber has already greatly benefited our shared customers over the years,” Gonzalez adds. 

The integration of MES and LIMS has emerged as a pivotal component in the digital transformation journey within the pharma and biopharma industry, especially given the laboratory's critical role in the overall production and supply chain processes. Lars Hornung, Senior Principal Alliances & Technology Partners Software, Körber Business Area Pharma, elaborates: “For instance, as part of the manufacturing process, PAS-X MES triggers a sample request to the LIMS, and the LIMS communicates detailed sample data back to the MES, enabling efficient label printing for each sample. After sample collection, PAS-X MES sends a sample confirmation to LIMS, including additional information for Quality Control (QC) purposes. The laboratory conducts the tests, and LIMS manages the results, which are then transmitted back to MES for further processing. Therefore, seamless integration between these systems is vital to streamlining processes and eliminating human error.”